ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
E

ASCO 2022 on ImmunoCobiVem Study Interim Analysis: The Efficacy & Safety of Sequencing With Vemurafenib + Cobimetinib Followed by Atezo in Advanced BRAFV600+ Melanoma

By ASCO 2022 Conference Coverage FEATURING Elisabeth Livingstone
By ASCO 2022 Conference Coverage FEATURING Elisabeth Livingstone
124 views
June 13, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Skin
10:27

ASCO 2022 Updates on DREAMseq (Doublet, Randomized Evaluation in Adv…

ASCO 2022 Conference Coverage

M. Atkins

215 views
01:37

Lecture Summary - ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus …

ASCO 2022 Conference Coverage

A. Daud

15 views
18:11

ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus Two

ASCO 2022 Conference Coverage

A. Daud

270 views
14:22

ASCO 2022 Nivo + Rela vs. Nivo in Previously Untreated Metastatic/Un…

ASCO 2022 Conference Coverage

E. Lipson

336 views
02:01

Lecture Summary - ASCO 2022 Meta-Analysis of Randomized Phase II-III…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

11 views
09:28

ASCO 2022 Meta-Analysis of Randomized Phase II-III Trials Evaluating…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

110 views
05:48

ASCO 2022 on the Role of Metastasectomy in Advanced BRAF+ Melanoma D…

ASCO 2022 Conference Coverage

K. Orlova

300 views
04:30

ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Monotherapy in Advan…

ASCO 2022 Conference Coverage

J. Weber

118 views
50

Lecture Summary - ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Mo…

ASCO 2022 Conference Coverage

J. Weber

20 views
27

Lecture Summary - ASCO 2022 on Long-Term Toxicities With Immune Chec…

ASCO 2022 Conference Coverage

J. Tong

321 views
11:46

ASCO 2022 on Long-Term Toxicities With Immune Checkpoint Inhibitor i…

ASCO 2022 Conference Coverage

J. Tong

513 views
05:28

ASCO 2022 Primary Ipi/Nivo Followed by Adjuvant Nivo in Pts With Loc…

ASCO 2022 Conference Coverage

E. Cocorocchio

207 views
06:03

ASCO 2022 on Survival Update of Neoadjuvant Ipi + Nivo in Macroscopi…

ASCO 2022 Conference Coverage

J. Versluis

40 views
07:54

ASCO 2022 Phase II SECOMBIT Study on Optimal Treatment Sequencing in…

ASCO 2022 Conference Coverage

P. Ascierto

110 views
01:23

Lecture Summary - ASCO 2022 on Thromboembolism and Association With …

ASCO 2022 Conference Coverage

T. Sussman

13 views
08:48

ASCO 2022 on Thromboembolism and Association With Survival in Pts Wi…

ASCO 2022 Conference Coverage

T. Sussman

110 views
16:53

ASCO 2022: Real-World Evaluation of the Association Between Baseline…

ASCO 2022 Conference Coverage

Z. Eroglu

130 views
09:33

ASCO 2022 on ImmunoCobiVem Study Interim Analysis: The Efficacy & Sa…

ASCO 2022 Conference Coverage

E. Livingstone

124 views
55

Lecture Summary - ASCO 2022 Nivolumab + Relatlimab vs. Nivo in 1L Me…

ASCO 2022 Conference Coverage

P. Rutkowski

18 views
05:06

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…

ASCO 2022 Conference Coverage

P. Rutkowski

1.1K views
45

Lecture Summary - ASCO 2022 Long-Term Survival in Advanced Melanoma …

ASCO 2022 Conference Coverage

P. Rutkowski

13 views
04:49

ASCO 2022 Long-Term Survival in Advanced Melanoma for Pts Treated Wi…

ASCO 2022 Conference Coverage

P. Rutkowski

132 views
14:06

ASCO 2022 Analysis of the Effect of Systemic Corticosteroids on Surv…

ASCO 2022 Conference Coverage

A. Ikeguchi

58 views